Riyaz B. Email & Phone Number

• Led broad strategic innovation, research and development, and partnership initiatives to create novel bio-products using the latest advances in synthetic biology and metabolic engineering.• Developed and executed R&D and product development strategy.• Managed a team of scientists and delivered novel industrial strains producing various Omega-3-basedbioproducts geared towards cardiovascular and brain health in infants, adults, and senior citizens.

• Led open innovation initiatives to create novel consumer products using the latest advances in the microbiome and synthetic biology.• Vetted innovation opportunities in the health and wellness, personal care, and biotechnology sectors in North America, Europe, and beyond. • Conceived and executed ideas and research opportunities to bring new actives and breakthroughs in home and personal care to consumers.• Co-ordinated communication between external partners and internal KOL's.

New York, Ny, Us

GLG is the world’s insight network. We connect decision-makers to the right experts so they can act with the confidence that comes from true clarity and have what it takes to get ahead. Our network of experts is the world’s largest and most varied source of first-hand expertise, and we recruit hundreds of new experts every day. We bring the power of insight to every great professional decision.

New York, Ny, Us

Guidepoint connects clients with vetted subject matter experts—Advisors—from our global professional network. Our clients leverage the insights and perspectives shared by our Advisors to stay informed and make better business decisions. Our multinational client list includes nine of the top 10 global consulting firms, hundreds of hedge funds (including five of the largest firms), and many of the largest private equity firms and Fortune-ranked companies.

Boston, Ma, Us

Conceived ideas, and identified opportunities, and challenges faced by the biotechnology sector in delivering transformational consumer products.

Paris, Fr

• Identified innovation opportunities for L'Oreal Advanced Research on the US west coast. • Conceived novel ideas and research opportunities to bring new actives and breakthroughs in skincare to consumers.• Generated and presented reports to L’Oreal executives in the US and France describing cutting-edge advances in synthetic biology and skin microbiome.• Managed communication and coordination between external partners and internal R&D.• Supported the legal and business development teams in drafting, negotiating, and executing research agreements.

Alameda, Ca, Us

• Conceived research, designed experiments, and generated milestones for producing novel triglyceride oils in industrial microbes.• Conceived a scientific proposal resulting in an SBIR grant from USDA, National Institute of Food and Agriculture, to Checkerspot Inc. in 2017. • Member of the core founding team that presented scientific package resulting in Checkerspot being accepted into the “Illumina Accelerator Program” in San Francisco in 2017.

South San Francisco, California, Us

• Pioneered the development of molecular, genetic, and cell biological tools for modulating lipid production in an exotic microalgae host.• Developed and executed research strategies and presented quarterly reports and updates to external investors and joint development partners.• Generated industrial strains with significantly boosted monounsaturated, polyunsaturated & and very-long-chain fatty acids, and provided concept products to partners.• Working as a team, metabolically engineered several strains for Solazyme's commercially produced high oleic culinary food oil "Thrive".

Bloomington, Indiana, Us

• Initiated experiments required for gaining NIH funding for two projects: Programmed Cell Death/Disease Resistance and Genetic Analysis of Disease Resistance in a model system. • Developed research methodologies to study immune responses and mechanisms of cell death under biotic stress conditions.• Established cell biological and cell sorting methods and mentored several Ph.D. students and fellow scientists.

Paris, France, Fr

• Designed and supervised the research of a doctoral student demonstrating the application and use of T-Sapphire and m-Orange as a donor/acceptor FRET-FLIM pair in reporting in vivo protein-protein interactions. The findings were published as a technical breakthrough and the fluorophores and methods described therein are being used in several laboratories around the world.• Set-up FRET microscopy especially FRET-FLIM at the Institute for Biotechnology & Environmental Biology, CEA, Cadarache, France.

Köln, De

• Identified and characterized novel lipid raft-like microdomains directly beneath pathogen attack sites within host cells. These findings were prominently featured as a focus article, “Pathogen Portals in Plants and Animals,” in Proceedings of the National Academy of Sciences (PNAS) (Vol. 102, pp. 2673-2674). The original research, recognized as a “fast-moving front paper” by Science Watch (January 2007), has accrued over 400 citations to date.• Contributed significant discoveries in the field of host-microbe interactions, resulting in multiple high-impact publications with a collective citation count exceeding 3,000.• Established a state-of-the-art imaging facility equipped with single- and multi-photon light microscopy, FRET-FLIM technology, and trained multiple research groups in the effective use of these advanced tools for their investigations.

Köln, De

Worked as a postgraduate researcher under the guidance of Prof. Dr. Richard D Thomson and graduated with a PhD degree in Genetics from University of Cologne in July 2002.

Executive Mba, Strategy, Partnerships, And Corporate Development

Doctor Of Science (Dr. Rer. Nat.), Molecular Genetics

Master Of Science - Ms, Biotechnology